Click on the link below to jump to the main contents on this page.
Apr 24, 2013
Meiji has launched a website for “Contracted development of microbial fermentation”
Apr 18, 2013
Meiji Initiates Phase 1 Clinical Trial of ME1111 in U.S. for Topical Treatment of Onychomycosis
Message from the President
Business Domains
Corporate Profile
History
R&D Activities
R&D Organizations
Product Pipeline
In compliance with the Pharmaceutical Affairs Act, Meiji Seika Pharma appoints a...
May 23, 2013
【Presentation】Financial Results for Fiscal Year Ended March 31, 2013(PDF:1156KB)
May 14, 2013
Consolidated Financial Results for the Fiscal Year Ended March 31, 2013(PDF:340KB)
May 14, 2013
Notice Concerning Differences between Consolidated Financial Forecasts and Actual Results for FYE 2013/3(PDF:20KB)
